Evidence map›Paper›PMID 39064923›Full record

ArticleMolecules (Basel, Switzerland)2024

Catalytic Performance of CuZnAl Hydrotalcite-Derived Materials in the Continuous-Flow Chemoselective Hydrogenation of 2-Methyl-2-pentanal toward Fine Chemicals and Pharmaceutical Intermediates.

Rahma Abid, Bartosz Zawadzki, Jaroslav Kocik, Grzegorz Słowik, Janusz Ryczkowski, Mirosław Krawczyk, Zbigniew Kaszkur, Izabela S Pieta, Anna Śrębowata

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rahma AbidInstitute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52 PL, 01-224 Warsaw, Poland.
Bartosz ZawadzkiInstitute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52 PL, 01-224 Warsaw, Poland.ORCID 0000-0003-4973-637X
Jaroslav KocikORLEN UniCRE a.s., Záluží 1, 436 70 Litvínov, Czech Republic.
Grzegorz SłowikDepartment of Chemical Technology, Faculty of Chemistry, Maria Curie-Skłodowska University, Plac Maria Curie-Skłodowskiej 3, 20-031 Lublin, Poland.ORCID 0000-0001-5825-7974
Janusz RyczkowskiDepartment of Chemical Technology, Faculty of Chemistry, Maria Curie-Skłodowska University, Plac Maria Curie-Skłodowskiej 3, 20-031 Lublin, Poland.
Mirosław KrawczykInstitute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52 PL, 01-224 Warsaw, Poland.ORCID 0000-0001-5241-9610
Zbigniew KaszkurInstitute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52 PL, 01-224 Warsaw, Poland.ORCID 0000-0003-4733-4334
Izabela S PietaInstitute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52 PL, 01-224 Warsaw, Poland.ORCID 0000-0002-3394-7116
Anna ŚrębowataInstitute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52 PL, 01-224 Warsaw, Poland.ORCID 0000-0002-9586-0278

Funding

National Science Center 2019/33/B/ST5/01271
6 · The paper itself

Abstract

Hydrotalcite-derived materials are eco-friendly, cheap, and efficient catalysts of different reactions. However, their application in liquid-phase hydrogenation could be more extensive. Hence, this work concerns the application of three hydrotalcite-derived materials with different CuZnAl molar ratios in the liquid-phase continuous-flow hydrogenation of 2-methyl-2-pentenal (MPEA) at a wide range of temperature (298-378 K) and pressure (1 × 10

Indexed as

2-methyl-2-penten-1-ol2-methyl-2-pentenal chemoselective hydrogenation2-methylpentanalporous hydrotalcite-derived materials

Identifiers

PMID39064923
PMCPMC11279871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.